BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 19337549)

  • 21. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
    Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of growth hormone treatment on arginine to asymmetric dimethylarginine ratio and endothelial function in patients with growth hormone deficiency.
    Setola E; Monti LD; Lanzi R; Lucotti P; Losa M; Gatti E; Galluccio E; Oldani M; Fermo I; Giovannelli M; Bosi E; Piatti P
    Metabolism; 2008 Dec; 57(12):1685-90. PubMed ID: 19013291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human insulin-like growth factor I (IGF-I): risks and benefits of normalizing blood IGF-I concentrations.
    Clark RG
    Horm Res; 2004; 62 Suppl 1():93-100. PubMed ID: 15761240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arterial properties in acromegaly: relation to disease activity and associated cardiovascular risk factors.
    Yaron M; Izkhakov E; Sack J; Azzam I; Osher E; Tordjman K; Stern N; Greenman Y
    Pituitary; 2016 Jun; 19(3):322-31. PubMed ID: 26873588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study.
    Smith JC; Evans LM; Wilkinson I; Goodfellow J; Cockcroft JR; Scanlon MF; Davies JS
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):493-501. PubMed ID: 11966742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular Disease in Acromegaly.
    Sharma MD; Nguyen AV; Brown S; Robbins RJ
    Methodist Debakey Cardiovasc J; 2017; 13(2):64-67. PubMed ID: 28740584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of growth hormone replacement therapy on plasma diacron-reactive oxygen metabolites and endothelial function in Japanese patients: The GREAT clinical study.
    Suzuki K; Yanagi K; Shimizu M; Wakamatsu S; Niitani T; Hosonuma S; Sagara M; Aso Y
    Endocr J; 2018 Jan; 65(1):101-111. PubMed ID: 29070768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE.
    Yuen KCJ; Biller BMK; Radovick S; Carmichael JD; Jasim S; Pantalone KM; Hoffman AR
    Endocr Pract; 2019 Nov; 25(11):1191-1232. PubMed ID: 31760824
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunoblot studies of the acid-labile subunit (ALS) in biological fluids, normal human serum and in children with GH deficiency and GH receptor deficiency before and after long-term therapy with GH or IGF-I respectively.
    Labarta JI; Gargosky SE; Simpson DM; Lee PD; Argente J; Guevara-Aguirre J; Rosenfeld RG
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):657-66. PubMed ID: 9497872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant IGF-I: Past, present and future.
    Bright GM
    Growth Horm IGF Res; 2016 Jun; 28():62-5. PubMed ID: 26822565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
    Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiological aspects of growth hormone and insulin-like growth factor-I.
    Lombardi G; Colao A; Cuocolo A; Longobardi S; Di Somma C; Orio F; Merola B; Nicolai E; Salvatore M
    J Pediatr Endocrinol Metab; 1997; 10(6):553-60. PubMed ID: 9467124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arterial stiffness: is it ready for prime time?
    Franklin SS
    Curr Cardiol Rep; 2007 Nov; 9(6):462-9. PubMed ID: 17999871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatopause: dismetabolic and bone effects.
    Lombardi G; Tauchmanova L; Di Somma C; Musella T; Rota F; Savanelli MC; Colao A
    J Endocrinol Invest; 2005; 28(10 Suppl):36-42. PubMed ID: 16550721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Large-artery stiffness, hypertension and cardiovascular risk in older patients.
    Blacher J; Safar ME
    Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):450-5. PubMed ID: 16265585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.
    Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Florimonte L; Salvatore M; Lombardi G
    J Clin Endocrinol Metab; 1999 Jan; 84(1):17-23. PubMed ID: 9920056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth hormone secretion and circulating insulin-like growth factor-I (IGF-I) and IGF binding protein-3 concentrations in children with sickle cell disease.
    Soliman AT; el Banna N; alSalmi I; De Silva V; Craig A; Asfour M
    Metabolism; 1997 Nov; 46(11):1241-5. PubMed ID: 9361679
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults.
    Woodhouse LJ; Mukherjee A; Shalet SM; Ezzat S
    Endocr Rev; 2006 May; 27(3):287-317. PubMed ID: 16543384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.